SCHEMBL17937531

SCHEMBL17937531

CC(CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)c1cccc(C(=O)O)n1)C(=O)O

nearest known ligand 0.73

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 13/20 0.73
▸ MMEL1 Q495T6 7/20 0.73
▸ ACE P12821 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18672591 1.00 MME (0.73) MMEMMEL1ACE
SCHEMBL12317250 1.00 MME (0.73) MMEMMEL1ACE
SCHEMBL12939468 0.87 MME (0.71) MMEMMEL1ACE
SCHEMBL18672732 0.86 MME (0.70) MMEMMEL1ACE
SCHEMBL17937513 0.86 MME (0.70) MMEMMEL1ACE
SCHEMBL12317311 0.86 MME (0.70) MMEMMEL1ACE
SCHEMBL18672635 0.86 MME (0.76) MMEMMEL1ACE
SCHEMBL8577902 0.86 MME (0.76) MMEMMEL1ACE
SCHEMBL18672848 0.85 MME (0.68) MMEMMEL1ACE
SCHEMBL12317315 0.85 MME (0.68) MMEMMEL1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3048100-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS Novartis AG (CH) 2016-07-27 — — EP disclosed
Send feedback